Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3488367019 | Product containing ruxolitinib (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3716506015 | Ruxolitinib-containing product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4612561000052111 | läkemedel som innehåller ruxolitinib | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing ruxolitinib (medicinal product) | Is a | Product containing protein-tyrosine kinase inhibitor (product) | false | Inferred relationship | Some | ||
| Product containing ruxolitinib (medicinal product) | Has active ingredient | Ruxolitinib | true | Inferred relationship | Some | 1 | |
| Product containing ruxolitinib (medicinal product) | Is a | Product containing Janus kinase inhibitor (product) | true | Inferred relationship | Some | ||
| Product containing ruxolitinib (medicinal product) | Is a | Medicinal product categorized by structure | false | Inferred relationship | Some | ||
| Product containing ruxolitinib (medicinal product) | Is a | Product containing enzyme inhibitor (product) | true | Inferred relationship | Some | ||
| Product containing ruxolitinib (medicinal product) | Is a | Product containing azole (product) | true | Inferred relationship | Some | ||
| Product containing ruxolitinib (medicinal product) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Product containing ruxolitinib (medicinal product) | Is a | Antineoplastic agent | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| ruxolitinib 5 mg, tablett | Is a | False | Product containing ruxolitinib (medicinal product) | Inferred relationship | Some | |
| ruxolitinib 10 mg, tablett | Is a | False | Product containing ruxolitinib (medicinal product) | Inferred relationship | Some | |
| Ruxolitinib 20 mg oral tablet | Is a | False | Product containing ruxolitinib (medicinal product) | Inferred relationship | Some | |
| Ruxolitinib 15 mg oral tablet | Is a | False | Product containing ruxolitinib (medicinal product) | Inferred relationship | Some | |
| Ruxolitinib 25 mg oral tablet | Is a | False | Product containing ruxolitinib (medicinal product) | Inferred relationship | Some | |
| Ruxolitinib-containing product in oral dose form | Is a | True | Product containing ruxolitinib (medicinal product) | Inferred relationship | Some | |
| Ruxolitinib only product | Is a | True | Product containing ruxolitinib (medicinal product) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR